| Samantha Saluti, | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-2821 | |
| Not Available |
| Full Name | Samantha Saluti |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184343113 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1443163 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Saluti, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-2821 | Samantha Saluti, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-2821 |
News Archive
Using novel computational and biochemical approaches, scientists have accurately designed and built from scratch 10 large protein icosahedra-polyhedra with 20 faces-similar to viral capsids that carry viral DNA.
Although GOP presidential hopeful Mitt Romney's campaign advisers say they don't anticipate the need to adjust their strategy to respond to the latest fracas over reproductive rights, news outlets analyze the possible repercussions of the dust-up regarding Missouri Republican Senate candidate Todd Akin's statements about "legitimate" rape and pregnancy.
News organizations continue to report on reactions to the Congressional Budget Office's analysis of the Senate health bill.
Blue Cross Blue Shield of Delaware (BCBSD) announced today that it has signed an affiliation agreement with Pennsylvania-based Highmark Inc. (Highmark) that will position BCBSD to remain a strong local leader in the health care marketplace. This announcement is the culmination of a four-year corporate strategic planning process for BCBSD.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
› Verified 2 days ago
Daeun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 Farrell St, Burlington, VT 05401 Phone: 802-651-0597 | |
Dr. Kyle Maxwell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 158 Cherry St, Burlington, VT 05401 Phone: 802-862-1562 | |
Lea Juzek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Shelburne Rd, Burlington, VT 05401 Phone: 802-860-3311 Fax: 802-860-2980 | |
Alan Mccampbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1127 North Ave Ste 11, Burlington, VT 05408 Phone: 802-862-7752 | |
Hae Ji Yoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Shelburne Rd, Burlington, VT 05401 Phone: 802-864-8154 | |
Dr. Sarah Abdalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Church St, Burlington, VT 05401 Phone: 803-651-1018 | |
Debra M Gibbs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Suite 1413, Burlington, VT 05401 Phone: 802-847-5519 Fax: 802-847-1076 |